Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 8/20 | 0.58 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.58 |
| ▸ | DHFR | P00374 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 3/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.46 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | CHAT | P28329 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL478036 | 1.00 | NFE2L2 (0.58) | NFE2L2TRPA1DHFRMAOBCYP19A1 | |
| SCHEMBL28051597 | 0.89 | NFE2L2 (0.48) | NFE2L2TRPA1DHFRMAOBCYP19A1 | |
| SCHEMBL2033487 | 0.87 | NFE2L2 (0.54) | NFE2L2TRPA1MAOBCYP19A1MAOA | |
| SCHEMBL2033485 | 0.87 | NFE2L2 (0.54) | NFE2L2TRPA1MAOBCYP19A1MAOA | |
| Hydrogen Sulfide SCHEMBL3374801 | 0.87 | NFE2L2 (0.65) | NFE2L2TRPA1DHFRMAOBCYP19A1 | |
| Hydrogen Sulfide SCHEMBL3375526 | 0.87 | NFE2L2 (0.65) | NFE2L2TRPA1DHFRMAOBCYP19A1 | |
| Hydrogen Sulfide SCHEMBL3374807 | 0.87 | NFE2L2 (0.65) | NFE2L2TRPA1DHFRMAOBCYP19A1 | |
| SCHEMBL10701359 | 0.85 | NFE2L2 (0.48) | NFE2L2TRPA1DHFRMAOBCYP19A1 | |
| SCHEMBL358118 | 0.85 | TRPA1 (0.70) | NFE2L2TRPA1 | |
| SCHEMBL3374804 | 0.85 | NFE2L2 (0.48) | NFE2L2TRPA1DHFRMAOBCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 446 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2005504663-A | — | — | 2005-02-17 | — | — | JP | claimed |
| US-20040262255-A1 | Fabrication method at micrometer-and nanometer-scales for generation and control of anisotropy of structural, electrical, optical and optoelectronic properties of thin films of conjugated materials | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2004-12-30 | — | — | US | claimed |
| EP-1434681-A1 | FABRICATION METHOD AT MICROMETER- AND NANOMETER- SCALES FOR GENERATION AND CONTROL OF ANISOTROPY OF STRUCTURAL, ELECTRICAL, OPTICAL AND OPTOELECTRONIC PROPERTIES OF THIN FILMS OF CONJUGATED MATERIALS | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2004-07-07 | — | — | EP | claimed |
| WO-2003031158-A1 | FABRICATION METHOD AT MICROMETER- AND NANOMETER- SCALES FOR GENERATION AND CONTROL OF ANISOTROPY OF STRUCTURAL, ELECTRICAL, OPTICAL AND OPTOELECTRONIC PROPERTIES OF THIN FILMS OF CONJUGATED MATERIALS | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2003-04-17 | — | — | WO | claimed |
| EP-0709226-A1 | Coating formulations for thermal papers | CIBA-GEIGY AG (CH) | 1996-05-01 | — | — | EP | claimed |
| JP-61017150-A | — | — | None | — | — | JP | disclosed |
| US-12641976-B2 | Display device test portion and production method for same | Sharp Display Technology Corporation (JP) | 2026-05-26 | — | — | US | disclosed |
| US-20260136793-A1 | DISPLAY DEVICE | SHARP KK (JP) | 2026-05-14 | — | — | US | disclosed |
| CN-117561559-B | Method for manufacturing display device | 夏普显示科技株式会社 | 2026-05-12 | — | — | CN | disclosed |
| CN-117651984-B | Display device | 夏普显示科技株式会社 | 2026-05-12 | — | — | CN | disclosed |
| US-20260123201-A1 | DISPLAY DEVICE | SHARP KK (JP) | 2026-04-30 | — | — | US | disclosed |
| US-12610616-B2 | Display device and method for manufacturing same | SHARP KABUSHIKI KAISHA (JP) | 2026-04-21 | — | — | US | disclosed |
| US-5928802-A | ORGANOMETALLIC COMPLEX LUMINESCENT MATERIALS FOR EFFICIENTLY PRODUCING BLUE LIGHT EMISSION | EASTMAN KODAK COMPANY (US) | 1999-07-27 | — | — | US | disclosed |
| EP-0878529-A2 | Novel blue luminescent materials for organic electroluminescent devices | EASTMAN KODAK COMPANY (US) | 1998-11-18 | — | — | EP | disclosed |
| US-5766779-A | Electron transporting materials for organic electroluminescent devices | EASTMAN KODAK COMPANY (US) | 1998-06-16 | — | — | US | disclosed |
| US-5755999-A | Blue luminescent materials for organic electroluminescent devices | EASTMAN KODAK COMPANY (US) | 1998-05-26 | — | — | US | disclosed |
| EP-0825803-A2 | Electron transporting materials for organic electroluminescent devices | EASTMAN KODAK COMPANY (US) | 1998-02-25 | — | — | EP | disclosed |
| EP-0825804-A2 | Blue organic electroluminescent devices | EASTMAN KODAK COMPANY (US) | 1998-02-25 | — | — | EP | disclosed |
| US-5645948-A | Blue organic electroluminescent devices | EASTMAN KODAK COMPANY (US) | 1997-07-08 | — | — | US | disclosed |
| JP-S6117150-A | ELECTROPHOTOGRAPHIC SENSITIVE BODY | RICOH CO LTD | 1986-01-25 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12610616-B2 | Display device and method for manufacturing same | ITK, BTK, ICOSLG | NFE2L2 4006/4885TRPA1 2030/4885DHFR 4797/4885 |
| US-20260136793-A1 | DISPLAY DEVICE | L1CAM, PTPRJ, EPHA4 | NFE2L2 861/4885TRPA1 888/4885DHFR 4682/4885 |
| US-20260123201-A1 | DISPLAY DEVICE | L1CAM, CD2, TLL1 | NFE2L2 2111/4885TRPA1 391/4885DHFR 4878/4885 |
| US-12641976-B2 | Display device test portion and production method for same | TES, ITK, EPHA4 | NFE2L2 4079/4885TRPA1 1403/4885DHFR 4636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.